Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller… - European journal of …, 2011 - Springer
Purpose The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser… - European journal of …, 2011 - edoc.unibas.ch
The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-demethylation
(CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active oxymorphone …
(CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active oxymorphone …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
O Kummer, F Hammann, C Moser… - … Journal of Clinical …, 2011 - search.ebscohost.com
Purpose: The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller… - European Journal of …, 2011 - infona.pl
Purpose The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller, J Drewe… - 2011 - pubmed.ncbi.nlm.nih.gov
Purpose The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller… - European Journal of …, 2011 - doc.rero.ch
Purpose: The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
O Kummer, F Hammann, C Moser… - European Journal of …, 2010 - europepmc.org
Purpose The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
[PDF][PDF] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller… - Eur J Clin …, 2011 - core.ac.uk
Purpose The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
demethylation (CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active …
[引用][C] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O KUMMER, F HAMMANN, C MOSER… - European journal of …, 2011 - pascal-francis.inist.fr
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and
pharmacodynamics of oxycodone CNRS Inist Pascal-Francis CNRS Pascal and Francis …
pharmacodynamics of oxycodone CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser… - … Journal of Clinical …, 2011 - search.proquest.com
The main metabolic pathways of oxycodone, a potent opioid analgetic, are N-demethylation
(CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active oxymorphone …
(CYP3A4) to inactive noroxycodone and O-demethylation (CYP2D6) to active oxymorphone …